信利國際(00732.HK):信利工業(汕尾)股份終止上市輔導備案
格隆匯1月3日丨信利國際(00732.HK)公佈,有關建議分拆公司間接全資附屬公司信利工業(汕尾)股份有限公司(前稱信利工業(汕尾)有限公司)並於中國一間證券交易所獨立上市,及向中國證券監督管理委員會廣東監管局提交上市輔導備案申請。
按照現行市況作出調整後,董事會決定終止上市輔導備案並於2025年1月3日向中國證券監督管理委員會廣東監管局作出終止申請。上述有關終止上市輔導備案的申請不會對公司的財政狀況或營運構成重大不利影響。公司將繼續監察市場變動並據此制訂建議分拆的策略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.